Log In
Print
BCIQ
Print
Print this Print this
 

JR-101

  Manage Alerts
Collapse Summary General Information
Company JCR Pharmaceuticals Co. Ltd.
DescriptionRecombinant glucocerebrosidase rDNA origin manafactured using serum-free culture technology
Molecular Target
Mechanism of ActionEnzyme replacement therapy
Therapeutic ModalityBiologic: Enzyme
Latest Stage of DevelopmentPreclinical
Standard IndicationGaucher's disease
Indication DetailsTreat Gaucher's disease
Regulatory Designation

Partner

GlaxoSmithKline plc


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today